ELAVL1 and inflammatory bowel disease: In our previous studies, we found declines in the levels of tissue HuR - along with inhibition of the growth of the intestinal mucosa - in patients with various illnesses, including inflammatory bowel disease (IBD) (Xiao et al, 2019; Li et al, 2020).